A newly published pooled analysis of the Organ Preservation in Patients with Rectal Adenocarcinoma (OPRA) trial and the CAO/ARO/AIO-12 trial by the German Rectal Cancer Study Group has confirmed the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback